Tomohide Yamazaki
- Immunology top 0.5%
- Immunotherapy and Immune Responses 10
- Immune Cell Function and Interaction 10
- T-cell and B-cell Immunology 8
- Psoriasis: Treatment and Pathogenesis 2
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 2
- Genetics top 5%
- Immunology and Allergy top 10%
-
- Growth Hormone and Insulin-like Growth Factors 2
-
- Lymphoma Diagnosis and Treatment 1
- Co-authors
- Hisaya AkibaHideo Yagita∥Miyuki AzumaKo OkumuraHideyuki IwaiChen DongNatalia Martín‐OrozcoXuexian O. Yang
- Cited by
- ImmunologyOncologyGenetics
- Partner nations
- United StatesJapanAustria
In The Last Decade
Tomohide Yamazaki
20 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Immunology 2.7k
- Oncology 1.6k
- Genetics 368
- Biological Psychiatry 27
- Immunology and Allergy 65
Countries citing papers authored by Tomohide Yamazaki
This map shows the geographic impact of Tomohide Yamazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohide Yamazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohide Yamazaki more than expected).
Fields of papers citing papers by Tomohide Yamazaki
This network shows the impact of papers produced by Tomohide Yamazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohide Yamazaki. The network helps show where Tomohide Yamazaki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomohide Yamazaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2013 | 15 | |
| 3 | 2012 | 3 | |
| 4 | 2011 | 1 | |
| 5 | 2010 | 44 | |
| 6 | 2010 | 1 | |
| 7 | 2009 | 32 | |
| 8 | T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunitybreakdown → | 2009 | 618 |
| 9 | 2009 | 238 | |
| 10 | 2008 | 27 | |
| 11 | 2008 | 15 | |
| 12 | 2008 | 425 | |
| 13 | 2007 | 42 | |
| 14 | 2006 | 21 | |
| 15 | 2005 | 302 | |
| 16 | 2005 | 116 | |
| 17 | The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Micebreakdown → | 2003 | 654 |
| 18 | 2003 | 106 | |
| 19 | Expression of Programmed Death 1 Ligands by Murine T Cells and APCbreakdown → | 2002 | 798 |
| 20 | 2002 | 64 |
About Tomohide Yamazaki
Tomohide Yamazaki is a scholar working on Immunology, Biological Psychiatry and Dermatology, having authored 20 papers that have together received 3.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (8 papers), Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Immunology (2.7k citations), Oncology (1.6k citations) and Genetics (368 citations). Tomohide Yamazaki has collaborated with scholars based in United States, Japan and Austria. Frequent co-authors include Hisaya Akiba, Hideo Yagita∥, Miyuki Azuma, Ko Okumura, Hideyuki Iwai, Chen Dong, Natalia Martín‐Orozco, Xuexian O. Yang, Yeonseok Chung and Hironori Matsuda. Their work appears in journals such as The Journal of Experimental Medicine, Blood and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.